Business Context and Reporting Period
Company: Acme United Corp.
Reporting Period: Fiscal year ended December 31, 1997.
Business Overview: A multinational producer of consumer products (scissors, shears, rulers, first aid kits) and medical products (disposable scissors, instruments, sterile procedure trays). Operations are conducted in the United States, Canada, England, and Germany through two primary segments: Consumer and Medical.
Key Financial Metrics
| Metric | 1997 | 1996 |
|---|---|---|
| Net Sales | $46.3 million | $47.5 million |
| Net Income | $0.2 million | $(3.2 million) Loss |
| Earnings Per Share (Basic) | $0.06 | $(0.95) |
| Operating Cash Flow | $(3.4 million) Used | $6.2 million Provided |
| Working Capital | $10.0 million | $6.0 million |
| Current Ratio | 1.86 to 1 | 1.48 to 1 |
| Total Long-Term Debt | $11.9 million | $8.4 million |
| Debt to Equity Ratio | 1.88 | 1.30 |
Segment Performance:
- Consumer: Sales of $32.8 million (Operating Profit: $1.8 million). U.S. sales grew 10% to $21.9 million.
- Medical: Sales of $13.4 million (Operating Profit: $2.2 million). Sales declined 6% due to the sale of certain marketing rights.
Material Changes vs. Prior Period
- Return to Profitability: The company returned to net income in 1997 ($0.2 million) after a net loss of $3.2 million in 1996, driven by cost reductions and a gain on the sale of marketing rights.
- Revenue Decline: Consolidated net sales decreased 3% to $46.3 million. However, revenues from ongoing operations increased 4% to $44.3 million, excluding the impact of divestitures.
- Divestitures and Acquisitions:
- Sold U.S. marketing rights for certain wound care products in March 1997 for approximately $2.0 million, resulting in an $0.85 million gain.
- Acquired the Rotex Division inventory from Esselte Canada in December 1997, expected to add $2.0 million in revenue in 1998.
- Restructuring: Continued consolidation of manufacturing facilities, shifting UK production to U.S. and German operations. UK headcount reduced from 51 to 20.
- Cash Flow: Operating cash flow turned negative ($3.4 million used) primarily due to increased inventory levels, contrasting with positive cash flow in 1996.
Guidance, Outlook, and Risks
Management Outlook:
- Management intends to aggressively increase sales and profits in 1998.
- Focus areas include the expanded VHA contract for medical kits, hospital kit conversions, and the launch of a new patented children's scissor (shipments beginning April 1998).
- Capital expenditures in the U.S. for 1998 are expected to exceed $1.0 million for machinery and equipment.
Risks and Contingencies:
- Liquidity: Long-term debt increased to fund working capital requirements. The company was in violation of its line of credit covenants at year-end regarding an overdraft, though a modification was secured in February 1998.
- Legal: Involved in environmental matters and numerous legal actions regarding latex products (as a distributor). Management believes these will not have a material adverse impact.
- Year 2000: A task force is assessing the impact; management believes it will not materially affect financial results.
- Dividends: No cash dividends were paid in 1997 or 1996; earnings are being retained to finance business improvements.
Investor Verification Checklist
- Debt Covenants: Verify the status of the line of credit modification secured in February 1998 and ongoing compliance with borrowing restrictions.
- Inventory Levels: Confirm that the significant increase in inventory ($14.1 million in 1997 vs. $10.4 million in 1996) is supported by sales demand and not indicative of obsolescence.
- Product Launch Success: Monitor the performance of the new children's scissor and the Rotex acquisition in 1998 to validate revenue growth projections.
- Legal Exposure: Track the resolution of ongoing latex product litigation to ensure no material financial impact materializes.
- Dividend Policy: Watch for announcements regarding the resumption of dividends, which management stated would occur only after a record of consistent earnings is achieved.